CA3044492A1 - Antibody assay - Google Patents

Antibody assay Download PDF

Info

Publication number
CA3044492A1
CA3044492A1 CA3044492A CA3044492A CA3044492A1 CA 3044492 A1 CA3044492 A1 CA 3044492A1 CA 3044492 A CA3044492 A CA 3044492A CA 3044492 A CA3044492 A CA 3044492A CA 3044492 A1 CA3044492 A1 CA 3044492A1
Authority
CA
Canada
Prior art keywords
tumour marker
panel
epcam
aif1
mmp9
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3044492A
Other languages
English (en)
French (fr)
Inventor
Jared Allen
Isabel MACDONALD
Andrea Murray
Christopher WELBERRY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Freenome Ltd
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Publication of CA3044492A1 publication Critical patent/CA3044492A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA3044492A 2016-11-25 2017-11-24 Antibody assay Abandoned CA3044492A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1619954.9 2016-11-25
GBGB1619954.9A GB201619954D0 (en) 2016-11-25 2016-11-25 Antibody assay
PCT/GB2017/053541 WO2018096351A1 (en) 2016-11-25 2017-11-24 Antibody assay

Publications (1)

Publication Number Publication Date
CA3044492A1 true CA3044492A1 (en) 2018-05-31

Family

ID=58073509

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3044492A Abandoned CA3044492A1 (en) 2016-11-25 2017-11-24 Antibody assay

Country Status (12)

Country Link
US (1) US20190376975A1 (cg-RX-API-DMAC7.html)
EP (1) EP3545309B1 (cg-RX-API-DMAC7.html)
JP (1) JP7249284B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190088510A (cg-RX-API-DMAC7.html)
CN (2) CN108107218B (cg-RX-API-DMAC7.html)
AU (1) AU2017365931A1 (cg-RX-API-DMAC7.html)
CA (1) CA3044492A1 (cg-RX-API-DMAC7.html)
GB (1) GB201619954D0 (cg-RX-API-DMAC7.html)
IL (1) IL266857A (cg-RX-API-DMAC7.html)
MX (1) MX2019006098A (cg-RX-API-DMAC7.html)
RU (1) RU2769987C2 (cg-RX-API-DMAC7.html)
WO (1) WO2018096351A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109633165B (zh) * 2018-12-18 2021-03-09 中国医学科学院基础医学研究所 抗hspa4自身抗体作为乳腺癌诊断或预后评估标志物的应用
CN109709335B (zh) * 2018-12-18 2020-10-27 中国医学科学院基础医学研究所 热休克蛋白hspa4在肿瘤转移预测、预后评估和治疗中的应用
US20220314021A1 (en) * 2019-02-19 2022-10-06 Otsuka Electronics Co., Ltd. Method for determining condition parameters for photodynamic therapy and photodynamic therapy apparatus
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
WO2022118947A1 (ja) * 2020-12-04 2022-06-09 富士フイルム和光純薬株式会社 抗体を測定する方法およびキット
CN114994318A (zh) * 2022-06-16 2022-09-02 深圳上泰生物工程有限公司 一种用于检测akr1b10的试剂盒及其制备方法
CN116444680B (zh) * 2022-12-28 2024-05-03 杭州凯保罗生物科技有限公司 一种ralgds-krt8-aif1融合肿瘤抗原蛋白的制备方法及其应用
CN119639903B (zh) * 2025-01-17 2025-11-25 中山大学肿瘤防治中心(中山大学附属肿瘤医院、中山大学肿瘤研究所) 用于肝内胆管癌的生物标记物、药物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387881B2 (en) * 2001-09-19 2008-06-17 The Regents Of The University Of Michigan Detection and treatment of cancers of the liver
ITPD20030264A1 (it) * 2003-10-30 2005-04-30 Xeptagen Spa Metodo di diagnosi altamente specifico per neoplasie
TWI281473B (en) * 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
CN1632589A (zh) * 2003-12-24 2005-06-29 财团法人工业技术研究院 肝脏疾病的生物标记分子及其检测方法
JP2010509598A (ja) * 2006-11-13 2010-03-25 ライフ テクノロジーズ コーポレーション 前立腺癌バイオマーカーを検出するための方法およびキット
TWI530686B (zh) * 2008-12-02 2016-04-21 財團法人工業技術研究院 用於肝纖維化診斷之生物標記
EP2405269B8 (en) * 2009-03-05 2016-10-12 National Institute of Advanced Industrial Science And Technology Method for detecting and distinguishing intrahepatic cholangiocarcinoma
US20120309034A1 (en) * 2010-02-12 2012-12-06 Nitto Boseki Co., Ltd. METHOD FOR MEASURING IMMUNITY OF COMPLEX OF Ku86 AND AUTOANTIBODY THEREOF, KIT USED THEREFOR, AND METHOD FOR DETERMINING CANCER USING SAME
CN102175864A (zh) * 2011-01-19 2011-09-07 江苏永鼎股份有限公司 一组早期肝癌分子标志物及其应用
CN102507938B (zh) * 2011-10-08 2014-12-24 复旦大学附属中山医院 一种肝癌转移预测定量抗体芯片及试剂盒
EP2875356A1 (en) * 2012-07-23 2015-05-27 INSERM - Institut National de la Santé et de la Recherche Médicale Method for diagnosing scleroderma
JP2014240771A (ja) * 2013-06-11 2014-12-25 日東紡績株式会社 Ku70/Ku86ヘテロダイマーに対する自己抗体の免疫測定方法、それに用いるキットおよびそれを用いた癌判定方法
GB201320061D0 (en) * 2013-11-13 2013-12-25 Electrophoretics Ltd Materials nad methods for diagnosis and prognosis of liver cancer
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
MY195045A (en) * 2014-07-02 2023-01-04 Dragon Victory Dev Ltd Specific Biomarker Set For Non-Invasive Diagnosis of Liver Cancer
CN104990905B (zh) * 2015-06-30 2017-12-29 曲凯 一种基于固相酶联免疫荧光斑点的肝癌转移诊断试剂盒

Also Published As

Publication number Publication date
IL266857A (en) 2019-07-31
EP3545309A1 (en) 2019-10-02
KR20190088510A (ko) 2019-07-26
RU2769987C2 (ru) 2022-04-12
JP7249284B2 (ja) 2023-03-30
CN108107218A (zh) 2018-06-01
JP2020515826A (ja) 2020-05-28
AU2017365931A1 (en) 2019-06-06
GB201619954D0 (en) 2017-01-11
BR112019010636A2 (pt) 2019-10-01
US20190376975A1 (en) 2019-12-12
WO2018096351A1 (en) 2018-05-31
RU2019118625A3 (cg-RX-API-DMAC7.html) 2021-03-31
RU2019118625A (ru) 2020-12-25
MX2019006098A (es) 2019-12-02
CN108107218B (zh) 2021-10-08
CN113655224A (zh) 2021-11-16
EP3545309B1 (en) 2021-03-31

Similar Documents

Publication Publication Date Title
EP3545309B1 (en) Antibody assay
EP2275815B1 (en) Improved immunoassay methods
CN106662586B (zh) 改进的免疫测定方法
NO342101B1 (no) In vitro fremgangsmåte for bestemmelse av antistoffprofil i en testprøve samt anvendelse av fremgangsmåten i diagnose, prognose eller overvåkningen av kreft
CN103257227B (zh) 改进的免疫测定方法
CA2799359C (en) Method for the diagnosis/prognosis of colorectal cancer
JP7744641B2 (ja) 肺癌における自己抗体を検出するための抗原の組合せの使用
TW201928351A (zh) 抗體測定
GB2600701A (en) Antibody assay
WO2017207616A9 (en) Diagnosis of cancer by detecting auto-antibodies against y box binding protein (yb-1)
CN113933509A (zh) 抗体测定
HK1152565B (en) Improved immunoassay methods
HK1152565A (en) Improved immunoassay methods

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20230524